Healthcare of Ontario Pension Plan Trust Fund Acquires 233,700 Shares of Oscar Health, Inc. (NYSE:OSCR)

Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Oscar Health, Inc. (NYSE:OSCR) by 155.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 383,700 shares of the company’s stock after purchasing an additional 233,700 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned 0.16% of Oscar Health worth $6,070,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in OSCR. Avalon Trust Co purchased a new stake in Oscar Health in the first quarter worth about $69,000. Point72 Hong Kong Ltd purchased a new stake in shares of Oscar Health in the 2nd quarter worth approximately $78,000. Quest Partners LLC bought a new position in Oscar Health during the 2nd quarter valued at approximately $93,000. Amalgamated Bank raised its stake in Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after buying an additional 1,458 shares during the last quarter. Finally, Farallon Capital Management LLC purchased a new position in Oscar Health during the first quarter valued at $164,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Buying and Selling

In other news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the transaction, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 169,569 shares of company stock valued at $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on OSCR. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Wells Fargo & Company lifted their target price on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $24.17.

Oscar Health Price Performance

OSCR opened at $20.15 on Friday. The company’s 50-day simple moving average is $18.86 and its two-hundred day simple moving average is $17.96. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $4.78 billion, a P/E ratio of -50.38, a P/E/G ratio of 41.58 and a beta of 1.62. Oscar Health, Inc. has a 52-week low of $4.72 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the prior year, the company earned ($0.07) earnings per share. Oscar Health’s revenue was up 44.6% on a year-over-year basis. As a group, analysts predict that Oscar Health, Inc. will post 0.01 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.